CUL4A and colorectal carcinoma: Notably, Shen et al. showed that treatment of HCT-116 cells with the KDM5 pan-inhibitor CPI-455 increased H3K4me3 levels which in turn led to increased cullin 4A expression and may promote CRC progression in a Wnt-dependent manner [147].